Staci Stevens

Staci R. Stevens, MA in exercise physiology. Founder and Director of Workwell Foundation, Ripon, California, USA. She serves as Co-Vice President of the Board of Directors and Chair of the Membership Committee of the International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. She served a term on the Chronic Fatigue Syndrome Advisory Committee from 2003 - 2006.

Stevens had (in her own words) a very well-controlled case of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) for greater than 20 years, which motivates her high commitment to advancing understanding of the illness and helping other patients.

Stevens is one of the authors of the 2011 case definition, International Consensus Criteria.

ME/CFS Common Data Element (CDE) Project
Member of the Quality of Life/Functional Status (CPET)/Activity Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention.

Talks and Interviews

 * 2009, Staci Steven speaking to CFSAC meeting
 * 2010, Slide presentation to CFSAC
 * 2011, "Effective Management of Activity Intolerance" - Staci R. Stevens, MA at the 10th International IACFSME Conference, Patient Agenda
 * 2012, MECFS Alert Episode 32: Staci Stevens, Director of the Pacific Fatigue Lab
 * 2012, Top 10 Things You Should Know About Post-Exertional Relapse
 * 2015, Video: Post-exertional malaise: How to do more with less, Staci Stevens, Vancouver BC Canada, May 2015

Notable studies

 * 2001, Assessment of Functional Impairment by Cardiopulmonary Exercise Testing in Patients with Chronic Fatigue Syndrome
 * 2001, Chronic Fatigue Syndrome, Ampligen, and Quality of Life: A Phenomenological Perspective (Abstract)
 * 2005, Exercise capacity and immune function in male and female patients with Chronic Fatigue Syndrome (CFS)
 * 2007, Legal and Scientific Considerations of the Exercise Stress Test
 * 2007, Diminished Cardiopulmonary Capacity During Post-Exertional Malaise
 * 2010, Post-exertional malaise in women with chronic fatigue syndrome
 * 2010, Conceptual model for physical therapist management of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
 * 2011, Diagnostic accuracy of symptoms characterising chronic fatigue syndrome
 * 2012, A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome (Full Text)
 * 2013, Discriminative validity of metabolic and workload measurements to identify individuals with Chronic Fatigue Syndrome (Full Text)
 * 2018, Editorial - Checking our blind spots: current status of research evidence summaries in ME/CFS. (Introduction)